Abstract
SummaryPlasma β‐melanocyte‐stimulating hormone (β‐MSH) levels were measured by radioimmunoassay in 10 women during the last trimester of normal pregnancy and in 21 women 40 to 95 days after delivery. It is concluded that β‐MSH cannot account for the increased circulating melanocyte‐stimulating activity that has previously been found in pregnancy when bioassays were used.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: The Journal of obstetrics and gynaecology of the British Commonwealth
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
